Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
- 31 August 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 100 (5), 1131-1132
- https://doi.org/10.1016/j.kint.2021.08.018
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19The New England Journal of Medicine, 2021
- Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant PatientsTransplantation, 2021
- Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant RecipientsTransplantation, 2021
- Neutralizing monoclonal antibodies for treatment of COVID-19Nature Reviews Immunology, 2021
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19The New England Journal of Medicine, 2021